Rectal neuroendocrine tumor with extracapsular lymph node metastasis: a case report.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 23 03 2021
accepted: 17 05 2021
pubmed: 25 5 2021
medline: 16 9 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

The presence of extramural tumor deposits without lymph node structure (EX) is an important prognostic factor in patients with colorectal carcinoma. However, there is no English literature on neuroendocrine tumor (NET) with EX. We report a patient with rectal NET with extracapsular metastasis of a regional lymph node that was considered to be EX. A 51-year-old Japanese woman with diabetes was referred to our hospital for further examination of a submucosal tumor in the lower rectum. She was diagnosed as having rectal NET by immunohistochemical analysis of a biopsy, and underwent laparoscopic low anterior resection with lymph node dissection and covering ileostomy. Pathological findings of the resected specimen showed that the primary tumor was NET-G1 without any lymphatic or venous invasion. A single metastatic deposit was found near the capsule of a NET-negative regional lymph node. She has been free from recurrence for nine months without adjuvant treatments. Extracapsular metastasis of NET on a dissected lymph node in our case was considered to correspond to EX as defined for colorectal carcinoma. This rare case suggests that NET can disseminate to form EX in a similar manner to colorectal carcinoma.

Identifiants

pubmed: 34028785
doi: 10.1007/s12328-021-01447-x
pii: 10.1007/s12328-021-01447-x
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1426-1430

Informations de copyright

© 2021. Japanese Society of Gastroenterology.

Références

Öberg K, Knigge U, Kwekkeboom D, et al. Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:VII124–30.
doi: 10.1093/annonc/mds295
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–59.
doi: 10.1002/cncr.11105
Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234–43.
doi: 10.1007/s00535-009-0194-8
Masui T, Ito T, Komoto I, et al. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer. 2020;20:1104.
doi: 10.1186/s12885-020-07581-y
NCCN Clinical Practice Guidelines in Oncology. Neuroendocrine tumor of the gastrointestinal tract, lung and thymus. Version 2; 2020.
Japan NeuroEndocrine Tumor Society (JNETS). Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN) 2019. 2nd ed. Tokyo: KANEHARA & Co., LTD; 2019.
Konishi T, Watanabe T, Kishimoto J, et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863–8.
doi: 10.1136/gut.2006.109157
Zhou X, Xie H, Xie L, et al. Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis. J Gastrointest Surg. 2013;17:1689–97.
doi: 10.1007/s11605-013-2249-7
Shields CJ, Tiret E, Winter DC, International Rectal Carcinoid Study Group. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg. 2010;252:750–5.
doi: 10.1097/SLA.0b013e3181fb8df6
Sohn B, Kwon Y, Ryoo SB, et al. Predictive factors for lymph node metastasis and prognostic factors for survival in rectal neuroendocrine tumors. J Gastrointest Surg. 2017;21:2066–74.
doi: 10.1007/s11605-017-3603-y
Brierley JD, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017.
Ueno H, Mochizuki H, Shirouzu K, et al. Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer. J Clin Oncol. 2011;29:2550–6.
doi: 10.1200/JCO.2010.33.7725
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal and anal carcinoma: the 3d English Edition. J Anus Rectum Colon. 2019;3:175–95.
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8.
doi: 10.1111/his.13975
Soga J. Carcinoids of the rectum: an evaluation of 1271 reported cases. Surg Today. 1997;27:112–9.
doi: 10.1007/BF02385898
Prabhudesai A, Arif S, Finlayson CJ, Kumar D. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum. 2003;46:1531–7.
doi: 10.1007/s10350-004-6809-5
Kimura K, Yamano T, Matsuda I, et al. Multiple rectal neuroendocrine tumors with recurrence of inguinal lymph nodes. Jpn J Gastroenterol Surg. 2018;51:170–7.
doi: 10.5833/jjgs.2017.0031
Klöppel G, Couvelard A, Perren A, et al. ENETS consensus guidelines for the standard care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009;90:162–6.
doi: 10.1159/000182196
Ramage JK, De Herder WW, Delle Fave G, et al. ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:139–43.
doi: 10.1159/000443166
Frilling A, Clift AK. Therapeutic strategies for neuroendocrine liver metastasis. Cancer. 2015;121:1172–86.
doi: 10.1002/cncr.28760

Auteurs

Akira Sakamoto (A)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. sakamotoa-sur@h.u-tokyo.ac.jp.

Hiroaki Nozawa (H)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hirofumi Sonoda (H)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Munetoshi Hinata (M)

Department of Pathology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hiroaki Ishii (H)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Shigenobu Emoto (S)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hiroyuki Anzai (H)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Yuichiro Yokoyama (Y)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Koji Murono (K)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Kazuhito Sasaki (K)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Kazushige Kawai (K)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Tetsuo Ushiku (T)

Department of Pathology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Soichiro Ishihara (S)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH